Last update:

Oncology & Cancer news

Oncology & Cancer

Study identifies genetic factors crucial in acute myeloid leukemia survival for Black patients

Researchers have led a global study that identified molecular predictors of survival among Black patients with acute myeloid leukemia (AML). The study suggests a need to modify current AML risk layers by including ancestry-specific ...

Oncology & Cancer

Dual immunotherapy plus chemotherapy found to benefit specific subset of patients with lung cancer

Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor ...

Oncology & Cancer

An AI-powered pipeline for personalized cancer vaccines

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses ...

Oncology & Cancer

Long-term study shows early prostate cancer surgery extended life

The survival rate of men with prostate cancer who had their entire prostate gland removed immediately after the tumor was detected increased by 17 percentage points compared with those who did not have treatment until the ...

Oncology & Cancer

Study uncovers mutations and DNA structures driving bladder cancer

How bladder cancer originates and progresses has been illuminated as never before in a study led by researchers at Weill Cornell Medicine and the New York Genome Center. The researchers found that antiviral enzymes that mutate ...

Oncology & Cancer

Do people with MS have an increased risk of cancer?

A study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. The study is published in the October 9, 2024, online issue of Neurology. Types of cancers found ...

Medical research

Study suggests possible way to 'Smac' cancer

In animals, a process of programmed cell death called apoptosis ensures cells die when they should. An opposing force, governed by inhibitor of apoptosis proteins (IAPs), guards against excessive cell death. Together these ...

Medical research

Epigenetic drugs in the mission to beat rare cancers

Only one in 100,000 people suffer from a pheochromocytoma, a tumor of the adrenal gland. If the tumor has already metastasized, a radioactive compound can be used to detect malignant cells that have spread to other parts ...

Medications

Drug combination shows potential in aggressive leukemia

Acute myeloid leukemia (AML) is an aggressive form of cancer that originates in the bone marrow, rapidly spreads to the blood, and can quickly cause death if not treated promptly. Despite recent therapeutic advances, it continues ...

Oncology & Cancer

Specialists show facial pain can be unconnected to teeth

What's the proper treatment for constant, inexplicable pain in the face, jaw or head that defies conventional dental treatment? According to researchers from the Rutgers School of Dental Medicine, the answer varies widely ...

Oncology & Cancer

Metabolic health may play role in obesity-related cancers

For up to 40 years, nearly 800,000 people from Sweden, Norway and Austria have been tracked based on how their BMI and metabolic health—that is, their blood pressure, blood glucose levels and blood fats—affect the risk ...

Oncology & Cancer

Nine common questions about genetic testing for cancer

Your genes play a role in nearly all areas of your health. A gene is like an instruction manual for your body that tells your body how to function, develop and stay healthy. People have about 20,000 genes in their bodies.